| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Core Binding Factor Alpha 1 Subunit | 13 | 2017 | 16 | 2.430 |
Why?
|
| Bone Neoplasms | 5 | 2017 | 59 | 1.490 |
Why?
|
| Breast Neoplasms | 5 | 2017 | 195 | 1.340 |
Why?
|
| Transcription Factors | 13 | 2010 | 104 | 0.910 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 35 | 0.810 |
Why?
|
| MAP Kinase Signaling System | 4 | 2016 | 22 | 0.650 |
Why?
|
| Cell Nucleus | 14 | 2011 | 42 | 0.620 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2014 | 16 | 0.560 |
Why?
|
| Cell Movement | 2 | 2017 | 41 | 0.530 |
Why?
|
| Autophagy | 1 | 2017 | 16 | 0.510 |
Why?
|
| Osteoblasts | 6 | 2011 | 36 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2017 | 60 | 0.490 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2016 | 12 | 0.470 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 6 | 0.470 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2014 | 1 | 0.440 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 23 | 0.430 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 2 | 0.410 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 2 | 0.410 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 7 | 0.410 |
Why?
|
| Animals | 18 | 2017 | 2083 | 0.400 |
Why?
|
| RNA Interference | 5 | 2017 | 19 | 0.390 |
Why?
|
| Signal Transduction | 6 | 2017 | 242 | 0.320 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 19 | 0.300 |
Why?
|
| Mice | 11 | 2016 | 756 | 0.300 |
Why?
|
| Humans | 22 | 2017 | 12210 | 0.290 |
Why?
|
| Cell Proliferation | 6 | 2016 | 88 | 0.290 |
Why?
|
| DNA-Binding Proteins | 6 | 2010 | 151 | 0.280 |
Why?
|
| Cell Line, Tumor | 5 | 2014 | 126 | 0.280 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2014 | 4 | 0.260 |
Why?
|
| Protein Transport | 6 | 2017 | 15 | 0.250 |
Why?
|
| Neoplasm Proteins | 2 | 2003 | 28 | 0.250 |
Why?
|
| Neoplasm Invasiveness | 3 | 2014 | 34 | 0.240 |
Why?
|
| MCF-7 Cells | 2 | 2017 | 8 | 0.230 |
Why?
|
| Phosphorylation | 3 | 2014 | 78 | 0.230 |
Why?
|
| Neoplasms | 4 | 2008 | 94 | 0.220 |
Why?
|
| Epigenesis, Genetic | 3 | 2009 | 42 | 0.210 |
Why?
|
| Proteins | 4 | 2004 | 33 | 0.200 |
Why?
|
| Female | 5 | 2017 | 6967 | 0.200 |
Why?
|
| RNA, Small Interfering | 4 | 2014 | 45 | 0.200 |
Why?
|
| Transcription, Genetic | 7 | 2009 | 52 | 0.180 |
Why?
|
| Nuclear Proteins | 2 | 2014 | 43 | 0.180 |
Why?
|
| Prostatic Neoplasms | 2 | 2014 | 36 | 0.180 |
Why?
|
| Cell Differentiation | 3 | 2011 | 71 | 0.170 |
Why?
|
| Gene Expression Regulation | 6 | 2011 | 124 | 0.160 |
Why?
|
| Transcriptional Activation | 3 | 2010 | 13 | 0.160 |
Why?
|
| Mice, SCID | 2 | 2017 | 22 | 0.150 |
Why?
|
| Neoplasm Metastasis | 2 | 2010 | 53 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 26 | 0.140 |
Why?
|
| Gene Expression | 4 | 2009 | 97 | 0.130 |
Why?
|
| Autophagosomes | 1 | 2017 | 1 | 0.130 |
Why?
|
| Acetylation | 1 | 2017 | 4 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 7 | 0.130 |
Why?
|
| Chloroquine | 1 | 2017 | 2 | 0.130 |
Why?
|
| Tubulin | 1 | 2017 | 10 | 0.130 |
Why?
|
| Cell Adhesion | 1 | 2017 | 22 | 0.130 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 14 | 0.130 |
Why?
|
| Microtubules | 1 | 2017 | 18 | 0.130 |
Why?
|
| Transfection | 1 | 2017 | 59 | 0.130 |
Why?
|
| Cell Line | 2 | 2014 | 149 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 99 | 0.120 |
Why?
|
| Benzamides | 1 | 2016 | 8 | 0.120 |
Why?
|
| Aniline Compounds | 1 | 2016 | 14 | 0.120 |
Why?
|
| Metformin | 1 | 2016 | 9 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 42 | 0.110 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 3 | 2010 | 5 | 0.110 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2014 | 1 | 0.110 |
Why?
|
| Receptor Cross-Talk | 1 | 2014 | 2 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2014 | 5 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 16 | 0.110 |
Why?
|
| Epidermal Growth Factor | 1 | 2014 | 13 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 4 | 2010 | 39 | 0.110 |
Why?
|
| ErbB Receptors | 1 | 2014 | 31 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2011 | 157 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2014 | 36 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2005 | 27 | 0.110 |
Why?
|
| DNA | 2 | 2004 | 57 | 0.100 |
Why?
|
| Chromones | 1 | 2014 | 2 | 0.100 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2014 | 2 | 0.100 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2014 | 4 | 0.100 |
Why?
|
| Morpholines | 1 | 2014 | 7 | 0.100 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2014 | 2 | 0.100 |
Why?
|
| HeLa Cells | 4 | 2008 | 15 | 0.100 |
Why?
|
| Integrins | 1 | 2014 | 8 | 0.100 |
Why?
|
| Cell Survival | 1 | 2014 | 46 | 0.100 |
Why?
|
| Epitopes | 2 | 2004 | 17 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 22 | 0.100 |
Why?
|
| Bone Development | 2 | 2005 | 23 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 2 | 2004 | 43 | 0.100 |
Why?
|
| Apoptosis | 1 | 2014 | 104 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 89 | 0.100 |
Why?
|
| Osteolysis | 1 | 2014 | 66 | 0.100 |
Why?
|
| Cell Lineage | 2 | 2009 | 13 | 0.090 |
Why?
|
| Bone and Bones | 2 | 2010 | 83 | 0.090 |
Why?
|
| Amino Acids | 2 | 2008 | 8 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 20 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 15 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 22 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2008 | 35 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2010 | 1 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2010 | 1 | 0.080 |
Why?
|
| Models, Biological | 3 | 2007 | 191 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2010 | 12 | 0.080 |
Why?
|
| Nuclear Matrix | 3 | 2007 | 3 | 0.080 |
Why?
|
| Disease Progression | 1 | 2010 | 290 | 0.070 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2009 | 1 | 0.070 |
Why?
|
| Sterols | 1 | 2009 | 2 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 54 | 0.070 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 15 | 0.070 |
Why?
|
| Smad Proteins | 1 | 2008 | 2 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2009 | 84 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 21 | 0.070 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2007 | 6 | 0.060 |
Why?
|
| 3T3 Cells | 1 | 2005 | 7 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2005 | 12 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2005 | 16 | 0.060 |
Why?
|
| RNA | 1 | 2005 | 18 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 14 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2005 | 20 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 68 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2005 | 62 | 0.060 |
Why?
|
| Pluripotent Stem Cells | 1 | 2005 | 2 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2005 | 10 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2005 | 13 | 0.060 |
Why?
|
| Osteocytes | 1 | 2005 | 16 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2005 | 39 | 0.060 |
Why?
|
| Chondrogenesis | 1 | 2005 | 23 | 0.060 |
Why?
|
| Cartilage | 1 | 2005 | 41 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 4 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 29 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 35 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2003 | 17 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2003 | 46 | 0.050 |
Why?
|
| Vitamin D | 1 | 2003 | 10 | 0.050 |
Why?
|
| Male | 2 | 2014 | 6810 | 0.050 |
Why?
|
| Mitosis | 2 | 2009 | 3 | 0.040 |
Why?
|
| Core Binding Factor alpha Subunits | 2 | 2007 | 2 | 0.030 |
Why?
|
| Transcription Factor AP-2 | 2 | 2005 | 2 | 0.030 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2014 | 3 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 4 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Chromatin | 2 | 2003 | 10 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 4 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2011 | 14 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 64 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 70 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2010 | 6 | 0.020 |
Why?
|
| SMARCB1 Protein | 1 | 2010 | 2 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2010 | 5 | 0.020 |
Why?
|
| Flavonoids | 1 | 2010 | 8 | 0.020 |
Why?
|
| Histones | 1 | 2010 | 13 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 10 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 61 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 101 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 10 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 28 | 0.020 |
Why?
|
| Mitochondria | 1 | 2009 | 33 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2009 | 15 | 0.020 |
Why?
|
| Nuclear Localization Signals | 1 | 2008 | 1 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 2 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 27 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 7 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 80 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 100 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 324 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2007 | 5 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 7 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2006 | 2 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 62 | 0.020 |
Why?
|
| Phenotype | 1 | 2006 | 156 | 0.020 |
Why?
|
| Mutation | 1 | 2006 | 175 | 0.010 |
Why?
|
| Smad5 Protein | 1 | 2005 | 1 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2005 | 6 | 0.010 |
Why?
|
| Point Mutation | 1 | 2005 | 19 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 26 | 0.010 |
Why?
|
| Mesoderm | 1 | 2005 | 14 | 0.010 |
Why?
|
| Stem Cells | 1 | 2005 | 16 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 2005 | 16 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 86 | 0.010 |
Why?
|
| Cell Physiological Phenomena | 1 | 2004 | 5 | 0.010 |
Why?
|
| Homeostasis | 1 | 2004 | 35 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 205 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2004 | 3 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2004 | 9 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 15 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 29 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 117 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 43 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 171 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 86 | 0.010 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2003 | 1 | 0.010 |
Why?
|
| Osteocalcin | 1 | 2003 | 23 | 0.010 |
Why?
|